Amphetamine stimulates Wnt3 increases in rat nucleus accumbens

NeuroReport

Volumn 23, Issue 14, 2012, Pages 846-850

  MacLeod, R John ^a   Moores, Margaret E ^a   Beninger, Richard J ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

catenin; amphetamine; glycogen synthase kinase 3 ; nucleus accumbens; pLRP6; Wnt3

Indexed keywords

AMPHETAMINE; BETA CATENIN; GLYCOGEN SYNTHASE KINASE 3BETA; LIPOPROTEIN RELATED PEPTIDE 6; PEPTIDE; RNA; SERINE; SODIUM CHLORIDE; THREONINE; TYROSINE; UNCLASSIFIED DRUG; WNT3 PROTEIN; WNT5A PROTEIN; WNT7A PROTEIN;

ANIMAL TISSUE; ARTICLE; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REACTION TIME; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; WNT SIGNALING PATHWAY;

AMPHETAMINE; AMPHETAMINE-RELATED DISORDERS; ANIMALS; BLOTTING, WESTERN; CENTRAL NERVOUS SYSTEM STIMULANTS; NUCLEUS ACCUMBENS; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WNT3 PROTEIN;

EID: 84865749049     PISSN: 09594965     EISSN: 1473558X     Source Type: Journal    
DOI: 10.1097/WNR.0b013e328357d868     Document Type: Article

References (25)

1. Beaulieu JM, Sotnikova TD, Yao WD, Kockeritz L,Woodgett JR, Gainetdinov RR, Caron MG. Lithium antagonizes dopamine-dependent behaviours mediated by an Akt/glycogen synthase kinase 3 signalling cascade. Proc Natl Acad Sci USA 2004; 101:5099-5104.
2. Valvezan AJ, Klein PS. GSK-3 and Wnt signalling in neurogenesis and bipolar disorder. Front Mol Neurosci 2012; 5:1.
3. Freland L, Beaulieu JM. Inhibition of GSK3 by lithium, from single molecules to signalling networks. Front Mol Neurosci 2012; 5:14.
4. Kaidanovich-Beilin O, Woodgett Jr. GSK-3: Functional insights from cell biology and animal models. Front Mol Neurosci 2011; 4:40.
5. Wang QM, Fiol CJ, DePaoli-Roach AA, Roach PJ. Glycogen synthase kinase-3b is a dual specificity kinase differentially regulated by tyrosine and serine-threonine phosphorylation. J Biol Chem 1994; 269:14566-14574.
6. Stambolic V, Woodgett Jr. Mitogen inactivation of glycogen synthase kinase-3b in intact cells via serine 9 phosphorylation. Biochem J 1994; 303:701-704.
7. Fan G, Ballou LM, Lin RZ. Phospholipase C-independent activation of glycogen synthase kinase-3b and C-terminal Src kinase by Gaq. J Biol Chem 2003; 278:52432-52436.
8. Fleckenstein AF, Volz TJ, Riddle EL, Gibb JW, Hanson GR. New insights into the mechanism of action of amphetamines. Annu Rev Pharmacol Toxicol 2007; 47:681-698.
9. Sutton LP, Rushlow WJ. The dopamine D2 receptor regulates Akt and GSK- 3 via Dvl-3. Int J Neuropsychopharmacol 2012; 15:965-979.
10. Sutton LP, Rushlow WJ. The effects of neuropsychiatric drugs on glycogen synthase kinase-3 signalling. Neuroscience 2011; 199:116-124.
11. Min C, Cho D, Kwon KJ, Kim KS, Shin CY, Kim KM. Novel regulatory mechanism of canonical Wnt signalling by dopamine D2 receptor through direct interaction with b-catenin. Mol Pharmacol 2011; 80:68-78.
12. Inestrosa NC, Arenas E. Emerging roles of Wnts in the adult nervous system. Nat Rev Neurosci 2010; 11:77-86.
13. Angers S, Moon RT. Proximal events in Wnt signal transduction. Nat Rev Mol Cell Biol 2009; 10:468-477.
14. Taelman VF, Dobrowolski R, Plouhinec JL, Fuentealba LC, Vorwald PP, Gumper L, et al. Wnt signalling requires sequestration of glycogen synthase kinase-3 inside multivesicular endosomes. Cell 2010; 143:1136-1148.
15. Gerdjikov TV, Ross GM, Beninger RJ. Place preference induced by nucleus accumbens amphetamine is impaired by antagonists of ERK or p38 MAP kinases in rats. Behav Neurosci 2004; 118:740-750.
16. Pacheco II, MacLeod RJ. CaSR stimulates secretion of Wnt5a from colonic myofibroblasts to stimulate CDX2 and sucrose-isomaltase using Ror2 on intestinal epithelia. Am J Physiol Gastrointest Liver Physiol 2008; 295:G748-G759.
17. Xu C,Wang J,Wu P, Xue Y, Zhu W, Li Q, et al. Glycogen synthase kinase 3b in the nucleus accumbens core is critical for methamphetamine-induced behavioural sensitization. J Neurochem 2011; 118:126-139.
18. Hyman SE, Malenka RC, Nestler EJ. Neural mechanisms of addiction: The role of reward-related learning and memory. Annu Rev Neurosci 2006; 29:565-598.
19. Tawk M, Makoukji J, Belle M, Fonte C, Trousson A, Hawkins T, et al. Wnt/bcatenin signalling is an essential and direct driver of myelin gene expression and myelinogenesis. J Neurosci 2011; 31:3729-3742.
20. Okamoto M, Inone K, Iwamura H, Terashima K, Soya H, Asashima M, Kuwabara T. Reduction in paracrine Wnt3 factors during aging causes impaired adult neurogenesis. FASEB J 2011; 25:3570-3582.
21. Okamoto H, Voleti B, Banasr M, Sarhan M, Duriv V, Girgenti M, et al. Wnt2 expression and signalling is increased by different classes of antidepressant treatments. Biol Psychiatr 2010; 68:521-527.
22. Li Y, Li B, Wan X, Zhang W, Zhang L, Tang S-J. NMDA receptor activation stimulates transcription-independent rapid Wnt5a protein synthesis via the MAPK signalling pathway. Mol Brain 2012; 5:1.
23. Dash PK, Johnson D, Clark J, Orsi SA, Zhang M, Zhao J, et al. Involvement of glycogen synthase kinase-3 signalling pathway in TBI pathology and neurocognitive outcome. PLoS One 2011; 6:e24648.
24. Niehrs C, Shen J. Regulation of Lrp6 phosphorylation. Cell Mol Life Sci 2010; 67:2551-2562.
25. Sutton LP, Honardoust D, Mouyal J, Rajakumar N, Rushlow WJ. Activation of the canonical Wnt pathway by the antipsychotics haloperidol and clozapine involves dishevelled-3. J Neurochem 2007; 102:153-169.